American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Investing

Rights Issue Prospectus

by admin April 5, 2024
April 5, 2024
Rights Issue Prospectus

Flynn Gold Limited (ASX: FG1, “Flynn” or “the Company”) has released its Prospectus announcement.

A renounceable pro-rata rights issue offer of one (1) fully paid ordinary new share (New Share) for every two (2) fully paid ordinary shares (Shares) held by shareholders with a registered address in Australia or New Zealand as at the Record Date (Eligible Shareholders) at an issue price of $0.03 (3 cents) per New Share to raise up to approximately $2.46 million before costs.

Every two (2) New Shares will be accompanied by one (1) free-attaching option (New Option), with each New Options with an exercise price of $0.075 (7.5 cents), expiring 30 months from issue and which, upon exercise, entitle the holder to one fully paid ordinary share in the Company.

The offer of New Shares and free-attaching New Options is referred to as the Rights Issue.

The Rights Issue is partially underwritten by Mahe Capital Pty Ltd [ABN 91 634 087 684] [AFSL 517246] (Underwriter) for $750,000 before costs (Underwritten Amount). A summary of the material terms of the Underwriting Agreement between the Company and the Underwriter is set out in Section 1.2.

This Prospectus also contains an offer of up to a maximum of 4,924,227 New Options to the Underwriter (and/or its nominee(s)) as part fees for underwriting the Rights Issue (Underwriter Option Offer).

The Rights Issue and the Underwriter Option Offer are collectively the Offers.

Click here for the full ASX Release

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
FPX Nickel Establishes Technical Advisory Committee with Representatives from Strategic Investors
next post
AM Resources Identifies 49 New Pegmatites on its Significant Land Package in the Austrian Pegmatite Belt

Related Posts

Top 5 NASDAQ Pharma Stocks of 2024

July 18, 2024

John Hathaway: Gold Stocks “Ridiculously Cheap,” What Will...

February 28, 2024

Lucid Group stock price could be on the...

May 21, 2025

Behind the hype: Is Pi Network a $70...

May 21, 2025

3 key catalysts for the DAX index as...

January 27, 2025

Ares Management stock has soared, but there’s 1...

October 12, 2024

Canada Nickel Continues to Achieve Excellent Drill Results...

May 7, 2024

Red alert as Rolls-Royce share price forms bearish...

September 24, 2024

VIZSLA COPPER PROVIDES UPDATES ON WOODJAM COPPER-GOLD PROJECT...

February 22, 2024

Sui price prediction: 2 reasons it could hit...

May 23, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • GMS stock jumps 29% on takeover interest from Home Depot, QXO, analysts raise PTs

      June 22, 2025
    • Japan’s rice price surge: what’s driving it and why it could spark a political crisis

      June 22, 2025
    • BofA raises STOXX 600 target amid resilient global growth, warns on Mideast risks

      June 22, 2025
    • Palantir co-founder: US must prevent Iranian nukes

      June 22, 2025
    • Fed governor Waller advocates for July rate cut amid tariff, labor market outlook

      June 21, 2025

    Categories

    • Business (3,209)
    • Investing (2,537)
    • Latest News (2,000)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved